The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People

VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification

(2016) Martin Wehling et al.   AGE AND AGEING

The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly

(2016) Farhad Pazan et al.   DRUGS & AGING

Prevention of Hospital-Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial

(2016) Marie N. O'Connor et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Older People, a Plethora of Drugs, and Drug List Approaches: Useful, Efficacious, or a Waste of Time?

(2016) Martin Wehling   Journal of the American Medical Directors Association

Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design

(2015) A. Clegg et al.   AGE AND AGEING

Adaptación española de los criterios Beers

(2015) J. Pastor Cano et al.   Anales del Sistema Sanitario De Navarra

The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries

(2015) Anna Renom-Guiteras et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

(2015)   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review

(2015) Janine A Cooper et al.   BMJ Open

STOPP/START criteria for potentially inappropriate prescribing in older people: version 2

(2014) Denis O'Mahony et al.   AGE AND AGEING

Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly

(2013) Alexandra M. Kuhn-Thiel et al.   DRUGS & AGING

Clinical consequences of polypharmacy in elderly

(2013) Robert L Maher et al.   Expert Opinion On Drug Safety

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study

(2012) Karen Barnett et al.   LANCET

Why the exclusion of older people from clinical research must stop

(2012) G. Watts   BMJ-British Medical Journal

GUIDELINE-DRIVEN POLYPHARMACY IN ELDERLY, MULTIMORBID PATIENTS IS BASICALLY FLAWED: THERE ARE ALMOST NO GUIDELINES FOR THESE PATIENTS

(2011) Martin Wehling   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Arzneimitteltherapie im Alter: Zu viel und zu wenig, was tun?

(2008) M Wehling   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT